New blood test could replace invasive cancer biopsies
NCT ID NCT04490564
First seen Jan 07, 2026 · Last updated Jun 12, 2026 · Updated 17 times
Summary
This study tested a new blood test (liquid biopsy) to find cancer markers in 135 people with head and neck, lung, or skin cancer. The goal was to see if the blood test works as well as a standard tissue biopsy. The study did not provide treatment but aimed to improve how doctors monitor cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aretaieio University Hospital of Athens
Athens, Attica, 11528, Greece
-
Bioclinic
Thessaloniki, Thessaloniki, 546 22, Greece
-
Metropolital Hospital
Piraeus, Piraeus, 18547, Greece
-
Sotiria Thoracic Diseases Hospital of Athens
Athens, Attica, 11527, Greece
-
University General Hospital of Alexandroupoli
Alexandroupoli, Alexandroupolis, 68100, Greece
-
University General Hospital of Athens Attikon
Athens, Attica, 124 62, Greece
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.